Delivery Order SPE2DB22D9353-SPE2DB25FX1TY

Award Date 3/25/25
Potential Completion Date 4/15/25
Potential Value $9.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,906.30 contract is for the supply of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,906.30 firm fixed-price contract is for the supply of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a pharmaceutical product, with a period of performance through June 10, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,925.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a specialized pharmaceutical product, with a period of performance through April 8, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,238.03 contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a pharmaceutical product, with a period of performance through June 10, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a $11,887.62 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML medical products, with a period of performance through July 17, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This firm fixed-price delivery order, valued at $40,443.20, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML to support the recurring pharmaceutical supply needs of military health facilities. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,925.08, is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML medical supplies to support the recurring pharmaceutical needs of military healthcare facilities. The contract is a firm fixed-price delivery order and is not associated with any set-aside designation,...
The U.S. Defense Logistics Agency (DLA) awarded a $3,940.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, which has a completion date of July 18, 2024, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product used to treat certain medical conditions. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,981.26 contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designations. However, DMS Pharmaceutical Group...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $54,432.80 fixed-price contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, with a performance period ending on November 25, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of...
  • SPE2DB22D9353
    Indefinite Delivery Contract
  • SPE2DB22D9353-SPE2DB25FX1TY
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,906.30, is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities.

DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of Department of Defense healthcare sites. The current delivery order is not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 6/24/25, 9:47 AM